Hormone-replacement therapy and lobular cancers: new deals and old myths

Luca Mariani, Claudio Robba, Giulia Moggio and Piero Sismondi Academic Department of Gynaecological Oncology, University of Turin Mauriziano Umberto I° Hospital of Turin & Institute for Cancer Research and Treatment of Candiolo, Turin, Italy “Several studies have reported that past and current users of combined hormone-replacement therapy are at a higher risk of developing invasive lobular carcinoma than invasive ductal–lobular mixed carcinoma.”